N,N-diethyl-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoylsulfamoyl)-1-methylpyrazole-5-carboxamide;3-[[2,6-di(propan-2-yl)phenyl]carbamoylsulfamoyl]-N,N,1-trimethylpyrazole-5-carboxamide;1-[2,6-di(propan-2-yl)phenyl]-3-[1-methyl-5-(pyrrolidine-1-carbonyl)pyrazol-3-yl]sulfonylurea;3-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoylsulfamoyl)-N,1-dimethyl-N-propan-2-ylpyrazole-5-carboxamide;3-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoylsulfamoyl)-N,1-dimethylpyrazole-5-carboxamide
C105H141N25O20S5 — CID 159360727
Data last refreshed: (MolForge compound catalog, from PubChem)
About N,N-diethyl-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoylsulfamoyl)-1-methylpyrazole-5-carboxamide;3-[[2,6-di(propan-2-yl)phenyl]carbamoylsulfamoyl]-N,N,1-trimethylpyrazole-5-carboxamide;1-[2,6-di(propan-2-yl)phenyl]-3-[1-methyl-5-(pyrrolidine-1-carbonyl)pyrazol-3-yl]sulfonylurea;3-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoylsulfamoyl)-N,1-dimethyl-N-propan-2-ylpyrazole-5-carboxamide;3-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoylsulfamoyl)-N,1-dimethylpyrazole-5-carboxamide
N,N-diethyl-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoylsulfamoyl)-1-methylpyrazole-5-carboxamide;3-[[2,6-di(propan-2-yl)phenyl]carbamoylsulfamoyl]-N,N,1-trimethylpyrazole-5-carboxamide;1-[2,6-di(propan-2-yl)phenyl]-3-[1-methyl-5-(pyrrolidine-1-carbonyl)pyrazol-3-yl]sulfonylurea;3-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoylsulfamoyl)-N,1-dimethyl-N-propan-2-ylpyrazole-5-carboxamide;3-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoylsulfamoyl)-N,1-dimethylpyrazole-5-carboxamide (PubChem CID 159360727) has the molecular formula C105H141N25O20S5 and a molecular weight of 2233.77 g/mol. Its IUPAC name is N,N-diethyl-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoylsulfamoyl)-1-methylpyrazole-5-carboxamide;3-[[2,6-di(propan-2-yl)phenyl]carbamoylsulfamoyl]-N,N,1-trimethylpyrazole-5-carboxamide;1-[2,6-di(propan-2-yl)phenyl]-3-[1-methyl-5-(pyrrolidine-1-carbonyl)pyrazol-3-yl]sulfonylurea;3-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoylsulfamoyl)-N,1-dimethyl-N-propan-2-ylpyrazole-5-carboxamide;3-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoylsulfamoyl)-N,1-dimethylpyrazole-5-carboxamide.
Molecular Properties
| Compound Name | N,N-diethyl-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoylsulfamoyl)-1-methylpyrazole-5-carboxamide;3-[[2,6-di(propan-2-yl)phenyl]carbamoylsulfamoyl]-N,N,1-trimethylpyrazole-5-carboxamide;1-[2,6-di(propan-2-yl)phenyl]-3-[1-methyl-5-(pyrrolidine-1-carbonyl)pyrazol-3-yl]sulfonylurea;3-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoylsulfamoyl)-N,1-dimethyl-N-propan-2-ylpyrazole-5-carboxamide;3-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoylsulfamoyl)-N,1-dimethylpyrazole-5-carboxamide |
|---|---|
| PubChem CID | 159360727 |
| Molecular Formula | C105H141N25O20S5 |
| Molecular Weight | 2233.77 g/mol |
| Exact Mass | 2231.94 |
| IUPAC Name | N,N-diethyl-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoylsulfamoyl)-1-methylpyrazole-5-carboxamide;3-[[2,6-di(propan-2-yl)phenyl]carbamoylsulfamoyl]-N,N,1-trimethylpyrazole-5-carboxamide;1-[2,6-di(propan-2-yl)phenyl]-3-[1-methyl-5-(pyrrolidine-1-carbonyl)pyrazol-3-yl]sulfonylurea;3-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoylsulfamoyl)-N,1-dimethyl-N-propan-2-ylpyrazole-5-carboxamide;3-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoylsulfamoyl)-N,1-dimethylpyrazole-5-carboxamide |
| SMILES | CC(C)N(C)C(=O)c1cc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)nn1C.CC(C)c1cccc(C(C)C)c1NC(=O)NS(=O)(=O)c1cc(C(=O)N(C)C)n(C)n1.CC(C)c1cccc(C(C)C)c1NC(=O)NS(=O)(=O)c1cc(C(=O)N2CCCC2)n(C)n1.CCN(CC)C(=O)c1cc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)nn1C.CNC(=O)c1cc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)nn1C |
| InChI | InChI=1S/2C22H29N5O4S.C22H31N5O4S.C20H29N5O4S.C19H23N5O4S/c1-13(2)26(3)21(28)18-12-19(24-27(18)4)32(30,31)25-22(29)23-20-16-9-5-7-14(16)11-15-8-6-10-17(15)20;1-4-27(5-2)21(28)18-13-19(24-26(18)3)32(30,31)25-22(29)23-20-16-10-6-8-14(16)12-15-9-7-11-17(15)20;1-14(2)16-9-8-10-17(15(3)4)20(16)23-22(29)25-32(30,31)19-13-18(26(5)24-19)21(28)27-11-6-7-12-27;1-12(2)14-9-8-10-15(13(3)4)18(14)21-20(27)23-30(28,29)17-11-16(25(7)22-17)19(26)24(5)6;1-20-18(25)15-10-16(22-24(15)2)29(27,28)23-19(26)21-17-13-7-3-5-11(13)9-12-6-4-8-14(12)17/h11-13H,5-10H2,1-4H3,(H2,23,25,29);12-13H,4-11H2,1-3H3,(H2,23,25,29);8-10,13-15H,6-7,11-12H2,1-5H3,(H2,23,25,29);8-13H,1-7H3,(H2,21,23,27);9-10H,3-8H2,1-2H3,(H,20,25)(H2,21,23,26) |
| InChIKey | LIMSNTAYECKRRG-UHFFFAOYSA-N |
| XLogP | 12.34 |
| TPSA | 575.79 Ų |
| H-Bond Donors | 11 |
| H-Bond Acceptors | 30 |
| Rotatable Bonds | 27 |
| Heavy Atoms | 155 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2233.77 |
| LogP ≤ 5 | 12.34 |
| H-Bond Donors ≤ 5 | 11 |
| H-Bond Acceptors ≤ 10 | 30 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159360727 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.